MYRX:OTCMKTS
Myrexis Inc
$0.00080
0.00%
(0.00) 1D
Oct 8, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MYRX...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
27.58K
Avg. vol.
24.00
Volume
500.00
52-wk high
$0.01
52-wk low
$0.00
Shares outstanding
34.48M
No. of employees
1
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
27.58K
Avg. vol.
24.00
Volume
500.00
52-wk high
$0.01
52-wk low
$0.00
Shares outstanding
34.48M
No. of employees
1
News stories
From web sources and news partners
marketscreener.com
·
18 minutes ago
S&P maintains UK's ratings at 'AA/A-1'
TradingView
·
17 minutes ago
Stocks close in green as tech selloff eases
ChartMill
·
1 hour ago
Friday's session: top gainers and losers in the dow jones index
Proactive financial news
·
3 hours ago
Frank Talk: Gold miners beat every S&P 500 sector in Q3 despite September selloff
Profile
Myrexis is an American biopharmaceutical company based in Salt Lake City, Utah. It was focused on drug development in several areas of medicine, in particular cancer therapy and auto-immune diseases.
It was developing three main cancer therapy drugs, Azixa, MPC-3100, and MPC-9528. After the failure of its most promising drug Azixa, in 2012, the company stopped all clinical trails and research and planned to be liquidated. However, instead of liquidation, the company stopped all activity and distributed most of its assets to shareholders, but continued as an entity looking for new investments. Wikipedia
About Myrexis Inc